IDSA guidelines on serologic testing for SARS-CoV-2
14 October 2020. Related: COVID-19: diagnostics, COVID-19.
Simon Collins, HIV i-Base
These US guidelines include eight recommendations on circumstances when use or not of different serologic tests might be considered for determining current or past SARS-CoV-2 infection.
The guidelines are produced by the Infectious Diseases Society of America (IDSA) and are based on comprehensive evidence reviews. However, the quality of evidence for the final recommendations is also noted as only being low to moderate.
Reference
Hanson KE et al. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing. Clinical Infectious Diseases, ciaa1343. DOI: 10.1093/cid/ciaa1343. (12 September 2020).
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1343/5904785
This report was first published on 16 September 2020.